Epidemiology of giant cell arteritis and polymyalgia rheumatica

Arthritis Care and Research

Volumn 61, Issue 10, 2009, Pages 1454-1461

  Gonzalez Gay, Miguel A ^a   Vazquez Rodriguez, Tomas R ^a   Lopez Diaz, Maria J ^a   Miranda Filloy, Jose A ^a   Gonzalez Juanatey, Carlos ^a   Martin, Javier ^b   Llorca, Javier ^c  

^a HOSPITAL XERAL CALDE   (Spain)

^b INSTITUTO DE PARASITOLOGÍA Y BIOMEDICINA LÓPEZ NEYRA   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD83 ANTIGEN; CD86 ANTIGEN; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; INTERLEUKIN 6; TOLL LIKE RECEPTOR 4;

AORTA ANEURYSM; BIOPSY; BLINDNESS; BLOOD VESSEL BIOPSY; CARDIOVASCULAR RISK; CAROTID ARTERY; CHLAMYDOPHILA PNEUMONIAE; ENVIRONMENTAL FACTOR; GIANT CELL ARTERITIS; HEREDITY; HUMAN; INCIDENCE; MACROPHAGE ACTIVATION; MYCOPLASMA PNEUMONIAE; PARVOVIRUS; PROGNOSIS; REVIEW; RHEUMATIC POLYMYALGIA; T LYMPHOCYTE ACTIVATION; VASCULITIS;

DATABASES, BIBLIOGRAPHIC; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; POLYMYALGIA RHEUMATICA; RISK FACTORS; WORLD HEALTH;

EID: 70349768112     PISSN: 21514658     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.24459     Document Type: Review

References (92)

1. Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis [review]. N Engl J Med 2002;347:261-271 (Pubitemid 34787634)
2. Gonzalez-Gay MA, Garcia-Porrua C. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001;27:729-749
3. Gonzalez-Gay MA, Barros S, Lopez-Diaz MJ, Garcia-Porrua C, Sanchez-Andrade A, Llorca J. Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients. Medicine (Baltimore) 2005;84:269-276 (Pubitemid 41368480)
4. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Hajeer AH, Branas F, Dababneh A, et al. Visual manifestations of giant cell arteritis: trends and clinical spectrum in 161 patients. Medicine (Baltimore) 2000;79:283-292 (Pubitemid 30752191)
5. Amor-Dorado JC, Llorca J, Garcia-Porrua C, Costa C, Perez- Fernandez N, Gonzalez-Gay MA. Audiovestibular manifestations in giant cell arteritis: a prospective study. Medicine (Baltimore) 2003;82:13-26. (Pubitemid 36139797)
6. Gonzalez-Gay MA, Garcia-Porrua C, Llorca J, Gonzalez- Louzao C, Rodriguez-Ledo P. Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. Semin Arthritis Rheum 2001;30:249-256 (Pubitemid 32172730)
7. Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, Olivieri I, Hunder GG. The spectrum of conditions mimicking polymyalgia rheumatica in northwestern Spain. J Rheumatol 2000;27:2179-2184 (Pubitemid 30701087)
8. Meliconi R, Pulsatelli L, Uguccioni M, Salvarani C, Macchioni P, Melchiorri C, et al. Leukocyte infiltration in synovial tissue from the shoulder of patients with polymyalgia rheumatica: quantitative analysis and influence of corticosteroid treatment. Arthritis Rheum 1996;39:1199-1207 (Pubitemid 26240235)
9. Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Niccoli L, et al. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med 1997;127:27-31. (Pubitemid 27283900)
10. Cantini F, Salvarani C, Olivieri I, Niccoli L, Padula A, Macchioni L, et al. Shoulder ultrasonography in the diagnosis of polymyalgia rheumatica: a case-control study. J Rheumatol 2001;28:1049-1055 (Pubitemid 32422588)
11. Cantini F, Niccoli L, Nannini C, Padula A, Olivieri I, Boiardi L, et al. Inflammatory changes of hip synovial structures in polymyalgia rheumatica. Clin Exp Rheumatol 2005;23:462-468 (Pubitemid 41447615)
12. Salvarani C, Barozzi L, Cantini F, Niccoli L, Boiardi L, Valentino M, et al. Cervical interspinous bursitis in active polymyalgia rheumatica. Ann Rheum Dis 2008;67:758-761 (Pubitemid 351829374)
13. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol 1998;25:1750-1755 (Pubitemid 28439269)
14. Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum 2004;33:289-293
15. Weyand CM, Hicok KC, Hunder GG, Goronzy JJ. Tissue cytokine patterns in patients with polymyalgia rheumatica and giant cell arteritis. Ann Intern Med 1994;121:484-491
16. Weyand CM, Goronzy JJ. Giant-cell arteritis and polymyalgia rheumatica. Ann Intern Med 2003;139:505-515
17. Weyand CM, Goronzy JJ. Arterial wall injury in giant cell arteritis [review]. Arthritis Rheum 1999;42:844-853
18. Weyand CM, Ma-Krupa W, Pryshchep O, Groschel S, Bernardino R, Goronzy JJ. Vascular dendritic cells in giant cell arteritis. Ann N Y Acad Sci 2005;1062:195-208.
19. Ma-Krupa W, Kwan M, Goronzy JJ, Weyand CM. Toll-like receptors in giant cell arteritis. Clin Immunol 2005;115:38-46. (Pubitemid 40616167)
20. Pryshchep O, Ma-Krupa W, Younge BR, Goronzy JJ, Weyand CM. Vessel-specific toll-like receptor profiles in human medium and large arteries. Circulation 2008;118:1276-1284
21. Weyand CM, Tetzlaff N, Bjornsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26. (Pubitemid 27044032)
22. Weyand CM, Ma-Krupa W, Goronzy JJ. Immunopathways in giant cell arteritis and polymyalgia rheumatica. Autoimmun Rev 2004;3:46-53. (Pubitemid 38197970)
23. Gonzalez-Gay MA, Hajeer AH, Dababneh A, Garcia-Porrua C, Amoli MM, Llorca J, et al. Interferon-γ gene microsatellite polymorphisms in patients with biopsy-proven giant cell arteritis and isolated polymyalgia rheumatica. Clin Exp Rheumatol 2004;22 Suppl 36:S18-20. (Pubitemid 41185513)
24. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitis in adults in Northwestern Spain, 1988-1997: clinical and epidemiologic aspects. Medicine (Baltimore) 1999;78:292-308.
25. Levine SM, Hellmann DB. Giant cell arteritis. Curr Opin Rheumatol 2002;14:3-10.
26. Gonzalez-Gay MA, Garcia-Porrua C. Systemic vasculitides. Best Pract Res Clin Rheumatol 2002;16:833-845
27. Barrier J, Pion P, Massari R, Peltier P, Rojouan J, Grolleau JY. Epidemiologic approach to Horton's disease in the department of Loire-Atlantique: 110 cases in 10 years (1970-1979). Rev Med Interne 1983;3:13-20. In French.
28. Salvarani C, Macchioni P, Zizzi F, Mantovani W, Rossi F, Castri C, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum 1991;34:351-356
29. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. The incidence of giant cell arteritis in Olmsted County, Minnesota: apparent fluctuations in a cyclic pattern. Ann Intern Med 1995;123:192-194
30. Sonnenblick M, Nesher G, Friedlander Y, Rubinow A. Giant cell arteritis in Jerusalem: a 12-year epidemiological study. Br J Rheumatol 1994;33:938-941 (Pubitemid 24324809)
31. Gran JT, Myklebust G. The incidence of polymyalgia rheumatica and temporal arteritis in the county of Aust Agder, south Norway: a prospective study 1987-1994. J Rheumatol 1997;24:1739-1743
32. Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, Perez- Alvarez R, Gonzalez-Juanatey C, Sanchez-Andrade A, et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore) 2007;86:61-68 (Pubitemid 46668055)
33. Boesen P, Sorensen SF. Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county: a prospective investigation, 1982-1985. Arthritis Rheum 1987;30:294-299 (Pubitemid 17098581)
34. Petursdottir V, Johansson H, Nordborg E, Nordborg C. The epidemiology of biopsy-positive giant cell arteritis: special reference top cyclic fluctuations. Rheumatology (Oxford) 1999;38:1208-1212
35. Franzen P, Sutinen S, von Knorring J. Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. J Rheumatol 1992;19:273-276
36. Bas-Lando M, Breuer GS, Berkun Y, Mates M, Sonnenblick M, Nesher G. The incidence of giant cell arteritis in Jerusalem over a 25-year period: annual and seasonal fluctuations. Clin Exp Rheumatol 2007;25 Suppl 44:S15-7. (Pubitemid 46656588)
37. Gonzalez-Gay MA, Garcia-Porrua C, Rivas MJ, Rodriguez- Ledo P, Llorca J. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis 2001;60:367-371 (Pubitemid 32242750)
38. Baldursson O, Steinsson K, Bjornsson J, Lie JT. Giant cell arteritis in Iceland: an epidemiologic and histopathologic analysis. Arthritis Rheum 1994;37:1007-1012 (Pubitemid 24222091)
39. Haugeberg G, Paulsen PQ, Bie RB. Temporal arteritis in Vest Agder County in southern Norway: incidence and clinical findings. J Rheumatol 2000;27:2624-2627 (Pubitemid 30847938)
40. Machado EB, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu CP, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-749
41. Salvarani C, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Reappraisal of the epidemiology of giant cell arteritis in Olmsted County, Minnesota, over a fifty-year period. Arthritis Rheum 2004;51:264-268
42. Smith CA, Fidler WJ, Pinals RS. The epidemiology of giant cell arteritis: report of a ten-year study in Shelby County, Tennessee. Arthritis Rheum 1983;26:1214-1219
43. Watts RA, Scott DG. Classification and epidemiology of the vasculitides. Baillieres Clin Rheumatol 1997;11:191-217.
44. Kobayashi S, Yano T, Matsumoto Y, Numano F, Nakajima N, Yasuda K, et al. Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey. Arthritis Rheum 2003;49:594-598
45. Gonzalez-Gay MA, Blanco R, Sanchez-Andrade A, Vazquez- Caruncho M. Giant cell arteritis in Lugo, Spain: a more frequent disease with fewer classic features. J Rheumatol 1997;24:2166-2170 (Pubitemid 27474039)
46. Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark: association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol 1996;23:112-119 (Pubitemid 26036005)
47. Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol 1995;34:261-264
48. Salvarani C, Gabriel SE, O'Fallon WM, Hunder GG. Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. Arthritis Rheum 1995;38:369-373
49. Gonzalez-Gay MA, Garcia-Porrua C, Vazquez-Caruncho M, Dababneh A, Hajeer A, Ollier WE. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol 1999;26:1326-1332 (Pubitemid 29268086)
50. Gabriel SE, Espy M, Erdman DD, Bjornsson J, Smith TF, Hunder GG. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum 1999;42:1255-1258 (Pubitemid 29268963)
51. Duhaut P, Bosshard S, Calvet A, Pinede L, Demolombe-Rague S, Dumontet C, et al, for the Groupe de Recherche sur l'Artérite à Cellules Géantes. Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. J Rheumatol 1999;26:361-369
52. Kinmont PD, McCallum DI. The etiology and course of giant cell arteritis: the possible role of light sensitivity. Br J Dermatol 1965;77:193-202.
53. Jonasson F, Cullen JF, Elton RA. Temporal arteritis: a 14-year epidemiological, clinical and prognostic study. Scott Med J 1979;24:111-117 (Pubitemid 9155714)
54. Llorca J, Bringas-Bollada M, Amor-Dorado JC, Garcia-Porrua C, Gonzalez-Gay MA. Lack of association between altitude and incidence of giant cell arteritis in northwest Spain [letter]. Clin Exp Rheumatol 2004;22:270. (Pubitemid 38444827)
55. Helweg-Larsen J, Tarp B, Obel N, Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology (Oxford) 2002;41:445-449
56. Regan MJ, Wood BJ, Hsieh YH, Theodore ML, Quinn TC, Hellmann DB, et al. Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls. Arthritis Rheum 2002;46:1056-1060
57. Salvarani C, Farnetti E, Casali B, Nicoli D, Wenlan L, Bajocchi G, et al. Detection of parvovirus B19 DNA by polymerase chain reaction in giant cell arteritis: a case-control study. Arthritis Rheum 2002;46:3099-3101 (Pubitemid 35315907)
58. Rodriguez-Pla A, Bosch-Gil JA, Echevarria-Mayo JE, Rossello- Urgell J, Solans-Laque R, Huguet-Redecilla P, et al. No detection of parvovirus B19 or herpesvirus DNA in giant cell arteritis. J Clin Virol 2004;31:11-15 (Pubitemid 39024378)
59. Gonzalez-Gay MA, Amoli MM, Garcia-Porrua C, Ollier WE. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum 2003;33:38-48. (Pubitemid 37046580)
60. Dababneh A, Gonzalez-Gay MA, Garcia-Porrua C, Hajeer A, Thomson W, Ollier W. Giant cell arteritis and polymyalgia rheumatica can be differentiated by distinct patterns of HLA class II association. J Rheumatol 1998;25:2140-2145 (Pubitemid 28505860)
61. Mattey DL, Hajeer AH, Dababneh A, Thomson W, Gonzalez- Gay MA, Garcia-Porrua C, et al. Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms. Arthritis Rheum 2000;43:1749-1755
62. Gonzalez-Gay MA, Rueda B, Vilchez JR, Lopez-Nevot MA, Robledo G, Ruiz MP, et al. Contribution of MHC class I region to genetic susceptibility for giant cell arteritis. Rheumatology (Oxford) 2007;46:431-434 (Pubitemid 46344653)
63. Gonzalez-Gay MA. Genetic epidemiology: giant cell arteritis and polymyalgia rheumatica. Arthritis Res 2001;3:154-7.
64. Rueda B, Lopez-Nevot MA, Lopez-Diaz MJ, Garcia-Porrua C, Martin J, Gonzalez-Gay MA. A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis. J Rheumatol 2005;32:1737-1741
65. Salvarani C, Casali B, Boiardi L, Ranzi A, Macchioni P, Nicoli D, et al. Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity. J Rheumatol 2000;27:1215-1221 (Pubitemid 30262507)
66. Amoli MM, Shelley E, Mattey DL, Garcia-Porrua C, Thomson W, Hajeer AH, et al. Intercellular adhesion molecule-1 gene polymorphisms in isolated polymyalgia rheumatica. J Rheumatol 2002;29:502-504 (Pubitemid 34202818)
67. Machado EB, Gabriel SE, Beard CM, Michet CJ, O'Fallon WM, Ballard DJ. A population-based case-control study of temporal arteritis: evidence for an association between temporal arteritis and degenerative vascular disease? Int J Epidemiol 1989;18:836-841
68. Duhaut P, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Ninet J, et al, on behalf of the Groupe de Recherche sur l'Artérite à Cellules Géantes. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Arthritis Rheum 1998;41:1960-1965
69. Gonzalez-Gay MA, Pineiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore) 2004;83:342-347 (Pubitemid 39541111)
70. Gonzalez-Gay M. The diagnosis and management of patients with giant cell arteritis. J Rheumatol 2005;32:1186-1188 (Pubitemid 40995367)
71. Klein RG, Campbell RJ, Hunder GG, Carney JA. Skip lesions in temporal arteritis. Mayo Clin Proc 1976;51:504-510
72. Lee AG, Brazis PW. Temporal arteritis: a clinical approach. J Am Geriatr Soc 1999;47:1364-1370
73. Duhaut P, Pinede L, Bornet H, Demolombe-Rague S, Dumontet C, Ninet J, et al, for the Groupe de Recherche sur l'Artérite à Cellules Géantes. Biopsy proven and biopsy negative temporal arteritis: differences in clinical spectrum at the onset of the disease. Ann Rheum Dis 1999;58:335-341
74. Taylor-Gjevre R, Vo M, Shukla D, Resch L. Temporal artery biopsy for giant cell arteritis. J Rheumatol 2005;32:1279-1282 (Pubitemid 40995383)
75. Mahr A, Saba M, Kambouchner M, Polivka M, Baudrimont M, Brocheriou I, et al. Temporal artery biopsy for diagnosing giant cell arteritis: the longer, the better? Ann Rheum Dis 2006;65:826-828
76. Hall S, Hunder GG. Is temporal artery biopsy prudent? Mayo Clin Proc 1984;59:793-796
77. Ponge T, Barrier JH, Grolleau JY, Ponge A, Vlasak AM, Cottin S. The efficacy of selective unilateral temporal artery biopsy versus bilateral biopsies for diagnosis of giant cell arteritis. J Rheumatol 1988;15:997-1000. (Pubitemid 18180689)
78. Gonzalez-Gay MA, Alonso MD, Aguero JJ, Bal M, Fernandez- Camblor B, Sanchez-Andrade A. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol 1992;19:277-280
79. Achkar AA, Lie JT, Hunder GG, O'Fallon WM, Gabriel SE. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis? Ann Intern Med 1994;120:987-992
80. Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, Llorca J. Giant cell arteritis without clinically evident vascular involvement in a defined population. Arthritis Rheum 2004;51:274-277
81. Rodriguez-Valverde V, Sarabia JM, Gonzalez-Gay MA, Figueroa M, Armona J, Blanco R, et al. Risk factors and predictive models of giant cell arteritis in polymyalgia rheumatica. Am J Med 1997;102:331-336 (Pubitemid 27249098)
82. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum 2003;48:3522-3531 (Pubitemid 37531919)
83. Gonzalez-Gay MA, Garcia-Porrua C, Pineiro A, Pego-Reigosa R, Llorca J, Hunder GG. Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from Northwestern Spain: a population-based study. Medicine (Baltimore) 2004;83:335-341 (Pubitemid 39541110)
84. Gonzalez-Juanatey C, Llorca J, Garcia-Porrua C, Sanchez- Andrade A, Martin J, Gonzalez-Gay MA. Steroid therapy improves endothelial function in patients with biopsy-proven giant cell arteritis. J Rheumatol 2006;33:74-78 (Pubitemid 43054283)
85. Gonzalez-Juanatey C, Llorca J, Martin J, Gonzalez-Gay MA. Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis. Semin Arthritis Rheum 2009;38:366-371
86. Gonzalez-Juanatey C, Lopez-Diaz MJ, Martin J, Llorca J, Gonzalez-Gay MA. Atherosclerosis in patients with biopsyproven giant cell arteritis. Arthritis Rheum 2007;57:1481-1486 (Pubitemid 350308847)
87. Maradit Kremers H, Reinalda MS, Crowson CS, Davis JM 3rd, Hunder GG, Gabriel SE. Glucocorticoids and cardiovascular and cerebrovascular events in polymyalgia rheumatica. Arthritis Rheum 2007;57:279-286
88. Uddhammar A, Eriksson AL, Nystrom L, Stenling R, Rantapaa- Dahlqvist S. Increased mortality due to cardiovascular disease in patients with giant cell arteritis in northern Sweden. J Rheumatol 2002;29:737-742 (Pubitemid 34308459)
89. Matteson EL, Gold KN, Bloch DA, Hunder GG. Long-term survival of patients with giant cell arteritis in the American College of Rheumatology giant cell arteritis classification criteria cohort. Am J Med 1996;100:193-196 (Pubitemid 26062514)
90. Gonzalez-Gay MA, Blanco R, Abraira V, Garcia-Porrua C, Ibanez D, Garcia-Pais MJ, et al. Giant cell arteritis in Lugo, Spain, is associated with low longterm mortality [published erratum appears in J Rheumatol 1998;25:193]. J Rheumatol 1997;24:2171-2176
91. Gran JT, Myklebust G, Wilsgaard T, Jacobsen BK. Survival in polymyalgia rheumatica and temporal arteritis: a study of 398 cases and matched population controls. Rheumatology (Oxford) 2001;40:1238-1242 (Pubitemid 33100089)
92. Doran MF, Crowson CS, O'Fallon WM, Hunder GG, Gabriel SE. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol 2002;29:1694-1697